Cargando…
Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease
BACKGROUND: Anti-glomerular basement-membrane (anti-GBM) disease (or Goodpasture disease) is characterized by severe kidney and lung involvement. Prognoses have improved with treatments that combine plasma exchange and immunosuppressive drugs. However, patients with severe renal involvement can have...
Autores principales: | Heitz, M., Carron, P. L., Clavarino, G., Jouve, T., Pinel, N., Guebre-Egziabher, F., Rostaing, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149204/ https://www.ncbi.nlm.nih.gov/pubmed/30236081 http://dx.doi.org/10.1186/s12882-018-1038-7 |
Ejemplares similares
-
Rituximab for Anti–Glomerular Basement Membrane Disease
por: Jain, Rashmi, et al.
Publicado: (2018) -
Rituximab for the treatment of refractory anti-glomerular basement membrane disease
por: Yang, Xue-Fen, et al.
Publicado: (2022) -
Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy
por: Bandak, Ghassan, et al.
Publicado: (2014) -
Rituximab for the Treatment of Anti-glomerular Basement Membrane Disease with Isolated Diffuse Alveolar Hemorrhage
por: Kanaoka, Kensuke, et al.
Publicado: (2022) -
Atypical anti-glomerular basement membrane disease
por: Troxell, Megan L., et al.
Publicado: (2016)